Landscapes / Companies
Cellogen Therapeutics Pvt. Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 0 checked
Trials
1 active
1 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Autologous bispecific CD20/CD19 CAR-T cellsnot checked |
— |
Phase 1 | 14 Sep 2028Phase 1 trial completes | ||
| Next date | 14 Sep 2028 · Phase 1 trial completes | ||||
| Also tested for | B-Cell Non-Hodgkin Lymphoma (NHL), B-cell Acute Lymphoblastic Leukemia (B-ALL) | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021